Skip to content

Health— page 2

health

Regeneron beats quarterly estimates on eczema drug strength, shares rise

July 30 (Reuters) – Regeneron on Thursday beat Wall Street estimates for second-quarter revenue and profit, helped by strong demand for its eczema drug Dupixent and a high-dose version of its eye drug Eylea. Shares rose nearly 5% before the bell. Here are the details: • Global net sales of Dupixent,

· SRN Health
Regeneron beats quarterly estimates on eczema drug strength, shares rise
health

UK reports rise in cyclospora infections linked to Mexico travel

July 30 (Reuters) – The UK Health Security Agency (UKHSA) said on Thursday it was seeing a sharp rise in cyclospora infections among travellers returning from Mexico and urged people to follow food and water hygiene measures while abroad. The agency said the parasite causes stomach illness, mainly t

· SRN Health
health

Pfizer’s oral drug restores skin pigmentation in late-stage vitiligo trials

July 30 (Reuters) – Pfizer said on Thursday its oral drug helped restore skin color in patients with a common form of vitiligo in two late-stage trials, paving the way for regulatory submissions seeking approval in the autoimmune skin disease. Here are the details: • The U.S. drugmaker was testing L

· SRN Health
Pfizer’s oral drug restores skin pigmentation in late-stage vitiligo trials
health

Baxter raises annual profit forecast on strength in drug compounding business

By Christy Santhosh July 30 (Reuters) – Baxter International on Thursday raised its annual profit forecast and beat Wall Street estimates for quarterly results, helped by strong sales in its drug-compounding business, sending its shares soaring 17% in morning trading. The medical products maker is i

· SRN Health
health

Sensodyne maker Haleon reaffirms targets on US and emerging markets growth

July 30 (Reuters) – British consumer health company Haleon on Thursday reported stronger-than-expected sales growth in North America, its largest market, and robust demand in emerging markets, helping it reaffirm its financial targets. The maker of Sensodyne toothpaste and Advil painkillers has been

· SRN Health
Sensodyne maker Haleon reaffirms targets on US and emerging markets growth
health

Sanofi lifts sales growth forecast on Dupixent strength in boost for new CEO

By Bhanvi Satija LONDON, July 30 (Reuters) – Sanofi raised its full-year sales forecast on Thursday, on the back of strong demand for blockbuster asthma drug Dupixent and newer products in the French drugmaker’s first results under new CEO Belen Garijo. Garijo has taken the helm at a time when the c

· SRN Health
Sanofi lifts sales growth forecast on Dupixent strength in boost for new CEO
health

Trump administration unfreezes $600 million for Gavi for global vaccine effort

By Ismail Shakil July 29 (Reuters) – The Trump administration said on Wednesday it will immediately release $600 million in congressionally appropriated funds for vaccines for the world’s poorest countries after Washington withheld the money over unsubstantiated safety concerns raised by U.S. Health

· SRN Health
Trump administration unfreezes $600 million for Gavi for global vaccine effort
health

Takeaways from Anthony Fauci’s COVID-era diaries

A diary played an unusual role in a contentious Senate hearing Wednesday – musings from Dr. Anthony Fauci, a scientist who became a leading voice in the U.S. response to the COVID-19 pandemic. Sen. Rand Paul, a Kentucky Republican, for years has accused Fauci, the longtime top infectious disease off

· SRN Health
Takeaways from Anthony Fauci’s COVID-era diaries
health

FDA panel votes against Capricor’s Duchenne heart disease therapy

By Christy Santhosh and Sahil Pandey July 29 (Reuters) – The U.S. FDA’s panel of independent advisers on Wednesday voted against effectiveness data of Capricor Therapeutics’ cell therapy, deramiocel, for a heart condition related to Duchenne muscular dystrophy. The nine-to-three vote aligns with FDA

· SRN Health
FDA panel votes against Capricor’s Duchenne heart disease therapy
health

J&J lowers 2026 profit forecast on deal costs, sees further hit in 2027

July 29 (Reuters) – Johnson & Johnson cut 2026 profit forecast on Wednesday, citing the combined financial impact of its newly completed acquisition of Firefly Bio and a strategic partnership with Sail Biomedicines. The healthcare giant expects full-year adjusted earnings per share of $10.96 to $11.

· SRN Health
J&J lowers 2026 profit forecast on deal costs, sees further hit in 2027
health

Study suggests the threat of mold-associated illnesses may be underappreciated

NEW YORK (AP) — A first-of-its-kind U.S. study suggests invasive mold infections may be an underappreciated — and potentially deadly — threat. The researchers detected about 450 cases in Atlanta-area hospitals over five years. About a third of the patients died in the hospital. The findings, publish

· SRN Health
Study suggests the threat of mold-associated illnesses may be underappreciated
health

US FDA approves first freeze-dried plasma product

By Siddhi Mahatole July 29 (Reuters) – The U.S. FDA on Wednesday approved the first freeze-dried plasma product for use in the country, providing an option for patients when conventional plasma is unavailable. The agency granted a biologics license to Vascular Solutions — a subsidiary of Teleflex —

· SRN Health
US FDA approves first freeze-dried plasma product
health

Brazil greenlights five new injectable diabetes drugs

By Luciana Magalhaes SAO PAULO, July 29 (Reuters) – Brazil’s health regulator Anvisa on Wednesday said it approved five new injectable GLP-1 drugs for diabetes and obesity treatment, capitalizing on a wave of expedited regulatory reviews following the expiration of Ozempic’s patent in the country in

· SRN Health
health

Cyclosporiasis cases in Michigan surpass 10,000 in ongoing outbreak

July 29 (Reuters) – Michigan health officials reported 10,077 cases of cyclosporiasis on Wednesday, an increase of 397 cases since their last update a day earlier. An investigation by the U.S. Food and Drug Administration has linked the outbreak to iceberg lettuce served at Taco Bell restaurants sou

· SRN Health
health

Processa buys Vidya Therapeutics, raises $200 million for drug trials

July 29 (Reuters) – Processa Pharmaceuticals said on Wednesday it acquired privately held Vidya Therapeutics in an all-stock deal, gaining access to its lead candidate being developed to target diseases involving the immune system. Shares of Processa, which also reported a share sale to raise about

· SRN Health
health

GE HealthCare tops quarterly estimates, weighs patient care unit sale

By Puyaan Singh July 29 (Reuters) – GE HealthCare said on Wednesday it might sell its patient care segment, after beating Wall Street estimates on steady demand for its diagnostics and imaging devices as well as tariff refunds. Shares of the company, which had already provided some preliminary secon

· SRN Health
GE HealthCare tops quarterly estimates, weighs patient care unit sale
health

Boston Scientific trims annual profit forecast on softer Watchman device demand

By Siddhi Mahatole July 29 (Reuters) – Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, citing slower growth for its Watchman heart device and tougher competition in its U.S. electrophysiology business. Shares were down nearly 3% in morning trade. The company’s upd

· SRN Health
Boston Scientific trims annual profit forecast on softer Watchman device demand
health

Health Rounds: MannKind injection helps heart failure patients avoid ER infusions

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By Nancy Lapid July 29 (Reuters) – We also report on an experimental diagnostic approach that can detect tuberculosis exposure and infection at an earlier stage than current method

· SRN Health
Health Rounds: MannKind injection helps heart failure patients avoid ER infusions
health

Humana leaves annual adjusted profit outlook unchanged, shares drop

By Sriparna Roy and Sneha S K July 29 (Reuters) – Humana stuck to its annual adjusted profit forecast on Wednesday for a second consecutive quarter, disappointing Wall Street and pushing the health insurer’s shares down 5% in morning trading. Investor expectations for health insurers have risen afte

· SRN Health
Humana leaves annual adjusted profit outlook unchanged, shares drop
health

US diners avoid restaurants as cyclosporiasis fears cut lettuce sales

By Tom Polansek and Anuja Bharat Mistry July 29 (Reuters) – U.S. consumers are steering clear of some restaurant chains and buying less lettuce in grocery stores as a multistate outbreak of a parasitic disease fuels confusion over what is safe to eat, according to foot traffic ​data and industry sou

· SRN Health
US diners avoid restaurants as cyclosporiasis fears cut lettuce sales
health

Biogen beats quarterly estimates as newer drugs fuel growth

July 29 (Reuters) – Biogen reported second-quarter profit and revenue that topped Wall Street estimates on Wednesday, driven by strong demand for its rare-disease medicines, while sales of its legacy multiple sclerosis drugs stayed under pressure. Investors are closely watching whether recent deals

· SRN Health
Biogen beats quarterly estimates as newer drugs fuel growth
health

Australia confirms H5N1 bird flu spreading in native bird population

SYDNEY, July 29 (Reuters) – Australia said on Wednesday the deadly H5N1 bird flu virus is being transmitted locally in the native bird population, raising concerns that the disease is beginning to spread more widely after it first appeared in the country in June. Minister for Agriculture, Fisheries

· SRN Health
Australia confirms H5N1 bird flu spreading in native bird population
health

CSL to start clinical trials for new immunoglobulin manufacturing process

July 29 (Reuters) – Australian biotechnology firm CSL said on Wednesday it would start clinical trials to support regulatory approval for a new manufacturing process aimed at lifting immunoglobulin output from the same amount of plasma. Here are the details: • CSL said the studies would test the saf

· SRN Health
health

A guide to the most common NFL injuries, from Achilles tendon tears to concussions

Injuries can play as big a role in an NFL team’s successes or failures as the best game plans. Depth is crucial during a rigorous 17-game regular season that’s preceded by a month of training camp practices in hot conditions and three preseason games as players try to make their team’s 53-man active

· SRN Health
A guide to the most common NFL injuries, from Achilles tendon tears to concussions